» Articles » PMID: 35897774

Caffeine-Induced Acute and Delayed Responses in Cerebral Metabolism of Control and Schizophrenia-Like Wisket Rats

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jul 28
PMID 35897774
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, morphological impairments have been detected in the brain of a triple-hit rat schizophrenia model (Wisket), and delayed depressive effects of caffeine treatment in both control and Wisket animals have also been shown. The aims of this study were to determine the basal and caffeine-induced acute (30 min) and delayed (24 h) changes in the cerebral fluorodeoxyglucose (F-FDG) uptake by positron emission tomography (PET) in control and Wisket rats. No significant differences were identified in the basal whole-brain metabolism between the two groups, and the metabolism was not modified acutely by a single intraperitoneal caffeine (20 mg/kg) injection in either group. However, one day after caffeine administration, significantly enhanced F-FDG uptake was detected in the whole brain and the investigated areas (hippocampus, striatum, thalamus, and hypothalamus) in the control group. Although the Wisket animals showed only moderate enhancements in the F-FDG uptake, significantly lower brain metabolism was observed in this group than in the caffeine-treated control group. This study highlights that the basal brain metabolism of Wisket animals was similar to control rats, and that was not influenced acutely by single caffeine treatment at the whole-brain level. Nevertheless, the distinct delayed responsiveness to this psychostimulant in Wisket model rats suggests impaired control of the cerebral metabolism.

Citing Articles

Distinct Effects of Olanzapine Depot Treatment on Behavior and Muscarinic M1 Receptor Expression in the Triple-Hit Wisket Rat Model of Schizophrenia.

Horvath G, Ducza E, Adlan L, Buki A, Kekesi G Genes Brain Behav. 2025; 24(1):e70015.

PMID: 39844699 PMC: 11754962. DOI: 10.1111/gbb.70015.


Effect of alpha-lipoic acid and caffeine-loaded chitosan nanoparticles on obesity and its complications in liver and kidney in rats.

Sawie H, Khadrawy Y, El-Gizawy M, Mourad H, Omara E, Hosny E Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(11):3017-3031.

PMID: 37306714 PMC: 10567965. DOI: 10.1007/s00210-023-02507-4.

References
1.
Zimmer E, Parent M, Souza D, Leuzy A, Lecrux C, Kim H . [F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017; 20(3):393-395. PMC: 5378483. DOI: 10.1038/nn.4492. View

2.
Molina V, Sanz J, Sarramea F, Benito C, Palomo T . Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity. J Psychiatr Res. 2004; 39(2):117-27. DOI: 10.1016/j.jpsychires.2004.06.008. View

3.
Potkin S, Alva G, Fleming K, Anand R, Keator D, Carreon D . A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry. 2002; 159(2):227-37. DOI: 10.1176/appi.ajp.159.2.227. View

4.
DallIgna O, da Silva A, Dietrich M, Hoffmann A, de Oliveira R, Souza D . Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice. Psychopharmacology (Berl). 2003; 166(3):258-63. DOI: 10.1007/s00213-002-1362-1. View

5.
Mitelman S, Buchsbaum M, Christian B, Merrill B, Buchsbaum B, Mukherjee J . Positive association between cerebral grey matter metabolism and dopamine D/D receptor availability in healthy and schizophrenia subjects: An F-fluorodeoxyglucose and F-fallypride positron emission tomography study. World J Biol Psychiatry. 2019; 21(5):368-382. DOI: 10.1080/15622975.2019.1671609. View